Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284038
Max Phase: Preclinical
Molecular Formula: C25H30O5
Molecular Weight: 410.51
Associated Items:
ID: ALA5284038
Max Phase: Preclinical
Molecular Formula: C25H30O5
Molecular Weight: 410.51
Associated Items:
Canonical SMILES: CCC(C)C(=O)c1c(O)c(CCC(C)C)c(O)c2c1OC(=O)CC2c1ccccc1
Standard InChI: InChI=1S/C25H30O5/c1-5-15(4)22(27)21-24(29)17(12-11-14(2)3)23(28)20-18(13-19(26)30-25(20)21)16-9-7-6-8-10-16/h6-10,14-15,18,28-29H,5,11-13H2,1-4H3
Standard InChI Key: RPPPZDIIFHACRY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 410.51 | Molecular Weight (Monoisotopic): 410.2093 | AlogP: 5.36 | #Rotatable Bonds: 7 |
Polar Surface Area: 83.83 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.59 | CX Basic pKa: | CX LogP: 6.73 | CX LogD: 6.51 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.36 | Np Likeness Score: 1.35 |
1. Gonçalves GA, Spillere AR, das Neves GM, Kagami LP, von Poser GL, Canto RFS, Eifler-Lima V.. (2020) Natural and synthetic coumarins as antileishmanial agents: A review., 203 [PMID:32668302] [10.1016/j.ejmech.2020.112514] |
Source(1):